SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-105159
Filing Date
2019-04-12
Accepted
2019-04-12 16:06:56
Documents
5
Period of Report
2019-05-17
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d683931ddef14a.htm DEF 14A 244542
2 GRAPHIC g683931g001.jpg GRAPHIC 881
3 GRAPHIC g683931g002.jpg GRAPHIC 698
4 GRAPHIC g683931g66m80.jpg GRAPHIC 45248
5 GRAPHIC g683931g89s35.jpg GRAPHIC 22346
  Complete submission text file 0001193125-19-105159.txt   341493
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 19746348
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1